We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNW icon
476
Pinnacle West Capital
PNW
$12.8B
$74.5K 0.02%
875
-1
-0.1% -$86
VCSH icon
477
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$74.4K 0.02%
930
JFR icon
478
Nuveen Floating Rate Income Fund
JFR
$1.23B
$74.1K 0.02%
6,255
-1
-0% -$12
IOO icon
479
iShares Global 100 ETF
IOO
$8.69B
$72.5K 0.02%
1,722
-2
-0.1% -$84
PGF icon
480
Invesco Financial Preferred ETF
PGF
$675M
$72.5K 0.02%
3,795
-1
-0% -$19
BAX icon
481
Baxter International
BAX
$12B
$72K 0.02%
1,190
SON icon
482
Sonoco
SON
$5.83B
$71.7K 0.02%
1,395
-1
-0.1% -$51
NVS icon
483
Novartis
NVS
$298B
$71.1K 0.02%
951
-390
-29% -$27.6K
IYC icon
484
iShares US Consumer Discretionary ETF
IYC
$1.14B
$71.1K 0.02%
1,732
-4
-0.2% -$165
NMT icon
485
Nuveen Massachusetts Quality Municipal Income Fund
NMT
$131M
$70.5K 0.02%
5,125
-1
-0% -$14
VNQ icon
486
Vanguard Real Estate ETF
VNQ
$39.9B
$70.4K 0.02%
846
-434
-34% -$36.2K
BND icon
487
Vanguard Total Bond Market
BND
$158B
$70.4K 0.02%
860
CRD.A icon
488
Crawford & Co Class A
CRD.A
$544M
$70K 0.02%
8,994
GM icon
489
General Motors
GM
$77.8B
$69.7K 0.02%
1,994
FDN icon
490
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.94B
$69.3K 0.02%
732
+120
+20% +$11.1K
BHC icon
491
Bausch Health
BHC
$1.7B
$69.2K 0.02%
4,000
+500
+14% +$5.99K
ADI icon
492
Analog Devices
ADI
$181B
$68.9K 0.02%
885
+285
+48% +$22.6K
ZBH icon
493
Zimmer Biomet
ZBH
$17.9B
$68.8K 0.02%
552
-181
-25% -$21.5K
KEY icon
494
KeyCorp
KEY
$24.2B
$68.5K 0.02%
3,656
+628
+21% +$11.4K
EVR icon
495
Evercore
EVR
$13B
$68.2K 0.02%
875
-3,375
-79% -$245K
VGT icon
496
Vanguard Information Technology ETF
VGT
$138B
$67.6K 0.02%
3,840
-480
-11% -$8.46K
ELV icon
497
Elevance Health
ELV
$82B
$67.5K 0.02%
359
-1
-0.3% -$180
FSK icon
498
FS KKR Capital
FSK
$3.03B
$67.5K 0.02%
1,844
JOYY
499
JOYY Inc
JOYY
$3.78B
$66.7K 0.02%
1,150
MBLY
500
DELISTED
Mobileye N.V.
MBLY
$66.5K 0.02%
1,065
+589
+124% +$36.5K

Similar funds

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.